Metastatic Disease

Explore clinical trials studying Metastatic Disease. Study availability and eligibility vary by location and protocol.

17 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

Metastatic Disease trial results

Completed

Stereotactic Radiation Therapy for Pediatric Sarcomas

NCT01763970

Conditions: Bony Sites, Metastatic Disease, Neoplasm Metastasis, +7 more
Locations: Stanford Medical Center Stanford, California, United States

Sibley Memorial Hospital Washington D.C., District of Columbia, United States

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Completed

Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary

NCT02628379

Conditions: CUP, Metastatic Disease, Neoplasm Metastasis, +8 more
Locations: Foundation Medicine, Inc Cambridge, Massachusetts, United States

View Trial Details

Completed

Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal Cancer

NCT01875380

Conditions: Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +13 more
Locations: Spanish Cooperative Group for Digestive Tumour Therapy (TTD) Madrid, Spain

View Trial Details

Completed

Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal

NCT00480389

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more
Locations: Princess Margaret Hospital, University Health Network Toronto, Ontario, Canada

View Trial Details

Completed

Study Using High-Dose Single Fraction Image-Guided Radiotherapy for Metastatic Lesions to Soft Tissue Masses, Lymph Node, or Bone

NCT00678158

Conditions: Metastatic Disease, Neoplasm Metastasis, Neoplasms, +3 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Completed

Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic

NCT01703910

Conditions: Adenocarcinoma of Colon, Adenocarcinoma of Rectum, Colonic Diseases, +17 more
Locations: Hospital Universitario de Fuenlabrada Fuenlabrada, Madrid, Spain

Hospital Madrid Norte Sanchinarro Madrid, Spain

View Trial Details

Completed

Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC)

NCT00609401

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +19 more
Locations: Istituto Tumori Milan, Italy

View Trial Details

Metastatic Disease

Metastatic Disease trial results

Stereotactic Radiation Therapy for Pediatric Sarcomas

Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary

Regorafenib in Frail and/or Unfit for Chemotherapy Patients With Metastatic Colorectal Cancer

Pre-operative Administration of Sorafenib in Patients With Metastatic Renal Cell Carcinoma Undergoing Kidney Removal

Study Using High-Dose Single Fraction Image-Guided Radiotherapy for Metastatic Lesions to Soft Tissue Masses, Lymph Node, or Bone

Study of Individualized Therapies Selection for Patients With Metastatic Colorectal Carcinoma According to the Therapeutic

Study Comparing Association Between Sorafenib and Interleukin-2 (IL-2) Versus Sorafenib in 1st Line Therapy in Advanced (Adv) Renal Cell Carcinoma (RCC)

Related conditions